WELCOME TO
APRICA HEALTHCARE
With dynamic strategies giving significant growth and sound quality throughout the product line, our patient-centric approach has marked our presence across the market we cover and segment we deal with.
INTENSIVE CARE
QUALITY
PATIENT CENTRIC
COMMUNITY
What’s Knocking
Day Today in Medical History: 16 April 2024
In 1992, thalidomide was reported by Johns Hopkins medical researchers to improve the survival rate of patients who get bone-marrow transplants. The drug effectively fought graft-versus-host disease, the most common and dangerous complication. Such transplants are standard treatments for potentially fatal disorders including aplastic anemia and some blood cancers. Thalidomide was previously known for years as among the most effective treatments for leprosy.
Our Products
Why choose Us
We apply one global quality standard across our facilities and product-line regardless of the market. Our vision tells the story of who we are as a company.
Read MoreOur Mission
At Aprica, We Vnnovate… since day one, It has been our CEO’s vision which truly reflects in everything we do. We are committed to provide best Quality products to our consumers.
Read MoreCommunity
A mission to deliver the foremost healthcare tools to patients for each aspect of their needs. It is to help in creating a bridge between a Doctor and a Patient through a mixture of advanced NextGen technology and Healthy Lifestyle Modifications.
Read More